Finance

Beta
Lists
COLL:NASDAQ
Collegium Pharmaceutical Inc
$34.60
-0.58%
(-0.20) 1D
Jun 11, 11:30:58 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for COLL...
Open
$34.51
High
$35.11
Low
$34.51
Mkt. cap
1.13B
Avg. vol.
433.42K
Volume
52.21K
P/E ratio
16.99
52-wk high
$50.79
52-wk low
$29.08
EPS
$2.04
Beta
0.74
Shares outstanding
32.43M
No. of employees
423
Open
$34.51
High
$35.11
Low
$34.51
Mkt. cap
1.13B
Avg. vol.
433.42K
Volume
52.21K
P/E ratio
16.99
52-wk high
$50.79
52-wk low
$29.08
EPS
$2.04
Beta
0.74
Shares outstanding
32.43M
No. of employees
423
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to COLL in the past 3 months
Strong Buy
Buy
5
Hold
1
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for COLL in the last 3 months.
Highest
Current $34.60
$60.00 (+73.42%)
Average
$53.40 (+54.35%)
Lowest
$44.00 (+27.18%)
News stories
From sources across the web
About Collegium Pharmaceutical Inc
CEO-
Employees423
Founded2002
Headquarters-
SectorPharmaceutical industry
Websitecollegiumpharma.com
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$1.76 / $1.52
+15.52%beat
Revenue / Est. (USD)
193.52M / 184.46M
+4.91%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
188.00M
209.36M
205.45M
193.52M
Cost of goods sold
22.19M
21.66M
21.60M
20.80M
Cost of revenue
22.19M
21.66M
21.60M
20.80M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
72.70M
65.55M
66.67M
86.35M
Operating expense
128.18M
121.02M
122.14M
141.82M
Total operating expenses
150.36M
142.68M
143.74M
162.62M
Operating income
37.64M
66.68M
61.71M
30.90M
Other non operating income
-
-
-
-
EBT including unusual items
17.02M
43.44M
29.04M
18.74M
EBT excluding unusual items
19.56M
48.03M
45.98M
18.74M
Income tax expense
5.04M
11.93M
12.07M
4.24M
Effective tax rate
29.62%
27.46%
41.58%
22.65%
Other operating expenses
-
-
-
-
Net income
11.98M
31.51M
16.96M
14.50M
Net profit margin
6.37%
15.05%
8.26%
7.49%
Earnings per share
1.68
2.25
2.04
1.76
Interest and investment income
2.38M
3.12M
3.56M
3.71M
Interest expense
-20.46M
-21.77M
-19.29M
-15.86M
Net interest expenses
-18.08M
-18.65M
-15.73M
-12.16M
Depreciation and amortization charges
-
-
-
-
EBITDA
94.24M
123.18M
118.11M
86.83M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer